Health Care

Analyst Today Rating: Medtronic plc (NYSE:MDT)


Medtronic plc (NYSE:MDT) surged +0.41% and closed the trade at $ 86.01. The company recorded a trading capacity of 7.78 million shares above its three months average daily volume of 4.45 million shares. During the last trade, shares reached to high price of $86.08 and touched the low price of $85.55. The stock’s 50-day moving average is noted at $87.02 and its 200-day moving average is stands at $82.38.

Additionally, the company has a PE ratio of 33.47 and has EPS of 2.57. The company has market capitalization of $118.86B.

Currently Medtronic plc (MDT) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “20″ Analysts”. “0” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $94.09 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $104.00 however minimum price target advised by analysts is $83.00. The Median price target for the stock is measured at $94.00.

Presently, Analysts decided consensus EPS estimate of $1.12 for present quarter and one month ago projected EPS estimate was at $1.14. If we take a look at back 3 month ago, consensus EPS estimate was $1.14.

A current consensus EPS estimate for next quarter is at $1.15 and 3 month ago EPS forecast was $1.15. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.15.

For current fiscal year, most recent EPS estimate is set at $4.65 based on Analyst consensus and three month ago consensus EPS opinions was at $4.67. During period one month ago, consensus EPS forecast was decided at $4.66.

A current consensus EPS projection for next fiscal year is observed at $5.18 and one month ago consensus EPS forecast was at $5.18. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.17 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 17 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 7 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 19 said a “Buy Rating” and 1 announced “Overweight Rating”. 7 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.